Triolein/cholesteryl oleate/cholesterol/phosphatidylcholine emulsions designed to model the lipid composition of chylomicrons were injected intravenously into control and streptozotocin-treated insulin-deficient rats. As previously described for lymph chylomicrons, the emulsion triolein was hydrolysed and phosphatidylcholine was transferred to the plasma high-density lipoprote-ins (HDL). This mechanism was used to introduce a phospholipid label into HDL in vivo. The subsequent clearance of phospholipid radioactivity from the plasma of insulin-deficient rats was significantly slower than in controls (P < 0.025). Plasma clearance was similarly slower in insulin-deficient rats after injection of HDL that was previously labelled with radioactive phospholipids. After injection, the phospholipid label redistributed rapidly between the large-particle fraction of plasma lipoproteins (very-low-and low-density lipoproteins), and the lighter and heavier fractions of HDL. Compared with control rats, in insulin-deficient rats less of the phospholipid label was distributed to the lighter HDL fraction and more to the heavier HDL fraction, and this difference was not due to changes in activity of lecithin: cholesterol acyltransferase or in the apparent activity of phospholipid transfer protein. In insulindeficient rats the changes in HDL phospholipid clearance and exchange appeared to be secondary to the associated hypertriglyceridaemia and the related changes in distribution of phospholipids between classes of plasma lipoproteins.
INTRODUCTION
Plasma HDL concentrations are inversely related to the incidence of atherosclerotic diseases and to plasma triacylglycerol concentrations in normal [1, 2] and hypertriglyceridaemic man [3, 4] . HDL are secreted by the liver [5] and intestine [6] as nascent particles, which then fuse with lamellar phospholipids, unesterified cholesterol and proteins liberated during lipoprotein lipase-mediated hydrolysis from the surfaces of triacylglycerolrich lipoproteins [7, 8] . Subsequent activity of LCAT produces mature plasma HDL.
The metabolism of the protein constituents of HDL has been described previously, but the metabolism of HDL phospholipids is poorly defined. HDL become enriched in phospholipids during alimentary chylomicronaemia in man [9] [10] [11] and after injection of lymph chylomicrons in rats [12, 13] . In rats treated with Triton WR1339 to inhibit lipoprotein lipase, the transfer of emulsion phospholipid radioactivity to HDL was decreased by about 72 % compared with controls [14] . The transfer of surface material, including phospholipid, from triacylglycerol-rich lipoproteins to HDL is substantial [13] , and provides a means for investigations of HDL dynamics in intact animals. Previously, when emulsions with lipid compositions similar to those of natural chylomicrons were injected, we found that labelled phospholipids were efficiently transferred from the emulsions to plasma HDL [15, 16] . The introduction of label into HDL by this mechanism facilitated the measurements of the turnover of HDL phospholipids. In the present study emulsions were injected into control rats and into rats made insulindeficient by treatment with streptozotocin. The metabolism of the protein moiety of HDL has been studied in diabetic rabbits [17] , rats [18] and man [19] , but the plasma clearance of HDL phospholipids has not been studied previously in diabetes.
MATERIALS AND METHODS Preparation of emulsions
Emulsions of the required compositions were prepared by sonication and purified by ultracentrifugation [16, 20] . Triolein (70 mg), cholesteryl oleate (3 mg), cholesterol (2 mg) (all from Nu-Chek Prep, Elysian, MN, U.S.A.) and l-palmitoyl-2-oleoyl phosphatidylcholine (POPC; 25 mg) (from Avanti Polar Lipids, Birmingham, AL, U.S.A.), each more than 990% pure, were dispensed from stock solutions into vials, followed by 30 ,tCi of dipalmitoyl phosphatidyl[N-methyl-3H]choline or 5,uCi of 1-palmitoyl-2-[l-14C]oleoyl phosphatidylcholine (Amersham, Sydney, Australia). Solvents were then evaporated under a stream of nitrogen before overnight desiccation to remove any residual solvent.
Mixtures of pure lipids were emulsified by sonication in 150 mM-NaCl in 10 mM-Hepes buffer (pH 7.4) . The lipids were sonicated in 8.5 ml of the NaCl buffer at 55-56°C (monitored by a thermocouple in the vessel), with the atmosphere above the mixture purged with nitrogen to prevent lipid oxidation. Sonication was for 20 min by using a 1 cm probe at a continuous output of 90-110 W with a Vibra-Cell high-intensity ultrasonic processor (Sonics and Materials Inc., Danbury, CT, U.S.A.). The density of the crude emulsion was increased to 1.21 g/ml by adding solid KBr. Then 4 ml portions were placed at the bottom of two centrifuge tubes, and 2.5 ml of NaCl solutions of densities 1.065, 1.020 and 1.006 g/ml were sequentially layered above. The tubes were centrifuged in the SW41 rotor of a Beckman L8-70M ultracentrifuge for 22 min at 24200 g (rav 11 cm) and 20 After surgery, the rats were placed in small individual cages [21] and allowed to recover from the effects of anaesthesia for 2-4 h.
Hydration of the rats and patency of the cannulas were maintained by injections of small volumes of 0.15M-NaCl solution. Heparin was not used. The dose of lipid injected was 2-5 mg containing approx. 500000 d.p.m., in an emulsion of volume 0.35-0.4 ml. Blood samples of 1 ml were then taken at 10, 20, 40, 60, 90 and 120 min after injection of an emulsion.
Over the 2 h period of study, the total volume removed amounted to approx. 20% of the blood volume. Ellman's reagent [5,5'-dithiobis-(2-nitrobenzoic acid)] was added to the blood samples to inhibit LCAT activity. After separation by centrifugation, radioactivity in the plasma was measured by liquid-scintillation spectroscopy by taking 30Il samples and adding 5 ml of Readysolv EP (Beckman). Immediately after completion of the clearance study, 20 mg of sodium pentobarbitone was injected, a blood sample (5 ml) was taken by heart puncture, and the liver and spleen were removed for extraction of lipids [22] with chloroform/methanol (2:1, v/v) and radioactivities in the purified lipid extracts were measured in 15 ml of scintillant.
Separation of HDL
To separate and subfractionate HDL, 6 ml of a sucrose solution of density 1.020 g/ml was placed in the left chamber and a solution of density 1.21 g/ml was placed in the right chamber of a gradient mixer. Solution from the right chamber was then pumped into a polyvinyl alcohol-coated [23] centrifuge tube, resulting in the flow of less dense solution from the left chamber to mix with the denser solution in the right chamber. In this manner a continuous sucrose gradient was formed of density of 1.050-1.21 g/ml. Solid NaBr (110 mg) was dissolved in 0.4 ml of rat plasma before the plasma was placed with a Pasteur pipette under the gradient. The 20 mg of sodium pentobarbitone was injected and a blood sample (8 ml) was taken by heart puncture. Clotting was prevented with EDTA (final concn. approx. 5 mm) and plasma was obtained by centrifugation. Density ranges corresponding to lighter HDL (1.080-1.11 g/ml) and heavier HDL (1.12-1.16 g/ml) were isolated from plasma by the technique described above for the separation of HDL. The fractions were dialysed against 0.15 M-NaCl/10 mM-Tris/HCI (pH 7.4)/0.01 % EDTA.
The fractions were then concentrated by vacuum ultrafiltration for injection into rats as described above for the emulsions, except that blood samples (1 ml) were taken 10, 20, 40 and 60 min after injection. Ellman's reagent was added to the blood samples to inhibit LCAT activity.
Preparation of the d> 1.21 fraction Rat plasma was increased in density to 1.21 g/ml by dissolving 5.91 g of NaBr in 20 ml of plasma, then placed into centrifuge tubes before overlaying with 19 ml of solution of density 1.21 g/ml. After centrifugation at 361000 g (ray 6 .6cm) for 15 h at 4°C in a fixed-angle 7OTi rotor, the bottom of the tube was punctured with an 18-gauge needle, and 20 ml of the infranatant was collected and dialysed against 0.15 M-NaCl/10 mM-Tris/HCl (pH 7.4), before concentration by vacuum ultrafiltration to a final volume of 5 ml.
LCAT activity in vivo
Emulsions labelled with l-palmitoyl- 20 1ul) were pipetted into each of three glass tubes (two samples and one blank) and mixed for 30 min at 37 'C. Then 30 ,ul of the albumin-stabilized [14C]cholesterol was added before incubation at 37 'C for 4 h. The reaction was started by addition of 20 ,ul of 0.1 M-mercaptoethanol. The reaction was stopped in tubes after 10, 20, 30 or 40 min by adding 5 ml of chloroform/methanol (2:1, v/v), followed by 2.5 ml of water. The chloroform phase was evaporated under nitrogen and the extracted lipids were separated by t.l.c. The cholesteryl ester bands were scraped into vials and the radioactivities measured in 5 ml of scintillant.
Phospholipid exchange in vitro
Labelled bilamellar vesicles were injected into control and insulin-deficient rats, and after 15 min labelled HDL was isolated from the plasma. The labelled HDL was then incubated with unlabelled plasma from control and insulin-deficient donor rats. After incubation, the mixtures were subfractionated by ultracentrifugation as described above and fractions were counted for radioactivity. All incubations were for 10 min in a shaking water bath at 37 'C.
In a second set of experiments, labelled HDL was incubated with unlabelled whole plasma from control donors in the presence of added amounts of the chylomicron-like emulsion. Parallel experiments were done where labelled HDL and plasma were obtained from insulin-deficient donors. In other incubations the d > 1.21 fraction obtained from control and insulin-deficient donors replaced whole plasma. After the incubations the lipoproteins were separated as above, and the d < 1.065 fractions were counted for radioactivity to determine the extent of phospholipid exchange and transfer to the VLDL + LDL fraction.
In a third set of experiments, labelled HDL and plasma from either control or insulin-deficient donors were incubated with 40 #1 emulsion. One incubation tube was immediately cooled to 0 'C, whereas duplicate tubes were incubated at 37 'C for 30 min or 60 min respectively and then cooled to 0 'C. Separation was as above, except that samples were ultracentrifuged at 0°C. In other incubations the d > 1.21 fractions replaced whole plasma.
Chemical analysis
The extracted lipids from the emulsions were separated by t.l.c. The triacylglycerol, cholesteryl ester and free cholesterol bands were scraped from the plate for assay of triacylglycerol by 853 the chromotropic acid method [25] , and for free and esterified cholesterol by the o-phthaldialdehyde procedure [26] . Protein assay was by the procedure of Lowry et al. [27] . Phospholipid was measured directly in emulsion suspensions and in total lipid extracts of plasma and HDL [28] . The size of emulsion particles was determined by electron microscopy after staining with osmium tetroxide [29] and by laser light scattering using a BI-90 particle sizer (Brookhaven Instruments Corp., Ronkonkoma, NY, U.S.A.). Table 1 shows that the insulin-deficient rats were hyperglycaemic and hypertriglyceridaemic. The plasma insulin was markedly decreased, and weight gain was less than for controls. The plasma phospholipid increased, but plasma cholesterol concentrations were unchanged in the insulin-deficient rats. HDL phospholipid was significantly increased by about 40 % compared with control rats.
RESULTS
Removal from plasma of labelled phospholipids
The removal rates of labelled phospholipid from plasma of control and insulin-deficient rats were compared after injection either as a component of chylomicron-like emulsions or as HDL from donor rats, labelled in vivo as described in the Materials and methods section. After injection of labelled emulsions, as shown in Fig. 1 , there was an initial rapid phase in which about 40 % of the phospholipid radioactivity disappeared from plasma within the first 10 min after injection. This rapid phase was consistent with previous findings of removal by the liver of 37"% of phospholipid radioactivity as partially lipolysed remnant particles 10 min after injection ofchylomicrons [30] . From 10 min onwards there was a slower monoexponential decrease of radioactivity, which continued for at least 2 h. The fractional removal rates calculated from the second phase are compared in Table 2 . There was a markedly slower rate of removal of phospholipid label from the plasma of insulin-deficient rats compared with controls (P < 0.025). As shown in Table 2 , emulsion radioactivities recovered in the liver and spleen 2 h after injection were similar in controls and insulin-deficient rats.
In insulin-deficient rats phospholipid was increased in plasma and HDL (Table 1) ; therefore the slow fractional clearance of phospholipid label could have been explained by an expansion of the pool size. By using the clearance rates given in Table 2 and assuming complete mixing with the whole plasma phospholipid pool, turnovers of 1.68 and 1.91 mg/min were calculated for control and insulin-deficient rats respectively. If complete mixing with the HDL pool only were assumed, then turnovers of HDL phospholipid would be very similar for controls and insulindeficient rats, at 0.58 and 0.62 mg/min respectively.
For comparison with the removal of phospholipid label from 12-1.16 ). The data are means + S.E.M. of samples taken between 10 and 120 min after injection of labelled emulsions in 8 control (O) and 6 insulin-deficient (U) rats. In insulin-deficient rats there was less label in the lighter HDL fraction, and more in the heavier HDL fraction, compared with controls: *significant difference (P < 0.001).
plasma after injection of emulsions, pre-labelled heavier HDL or lighter HDL was injected and plasma radioactivity was measured over 60 min. Table 2 shows that the clearance of phospholipid label from heavier HDL was significantly faster than that of label from emulsion, but again clearance from plasma was slower in insulin-deficient than in control rats. The removal rate of label from whole plasma of insulin-deficient rats after injection of labelled lighter HDL also appeared slower when compared with controls, but this difference was not statistically significant. As shown in Table 2 , the organ recoveries of phospholipid radioactivity in the liver and spleen after injection of the heavier HDL and the lighter HDL were similar.
Redistribution of plasma phospholipid label
Concurrent with the overall disappearance of phospholipid from plasma, there was a rapid redistribution of labelled phospholipid between lipoprotein fractions. By 10 min after injection of labelled emulsion, the phospholipid radioactivity was distributed between emulsion (< 1.065 g/ml), lighter (1.080-1.11 g/ml) and heavier (1.12-1.16 g/ml) HDL fractions in proportions which remained much the same for the ensuing 110 min, despite the disappearance during that time of 450% and 40% of injected label from the plasma of control and insulindeficient rats respectively. In insulin-deficient rats less of the HDL label was in the lighter HDL fraction, and more was in the heavier HDL, than in controls, whereas the d < 1.065 fraction contained a similar proportion of total label in both groups, as shown in Fig. 2 . After injection of labelled heavier HDL, an equilibrium distribution of phospholipid radioactivity was reached within 10 min and persisted until the end of the experiment at 60 min. The distribution can be compared in Fig. 3 with that when the HDL pool was labelled indirectly by injection of labelled emulsion (Fig. 2) . In Fig. 3(a) the labelled phospholipid was injected as lighter HDL, and in Fig. 3(b) Fractional removal rates were calculated over the period of 20-120 min after injection of emulsion and over the period min after injection of the HDL fractions. Organ uptakes were measured after killing at 120 min for the emulsion studies, and after 60 min for the HDL studies. Results are means+S.E.M. and n is the number of rats in each group: *significantly different from control rats (P < 0.025); tsignificantly faster than phospholipid clearance after injection of emulsion (P < 0.001); $significantly different from control rats (P < 0.05). 
LCAT activity in vivo
Whether labelled phospholipid was introduced intravenously on emulsion particles, as heavier HDL or as lighter HDL, less in proportion was distributed to the lighter HDL in insulin-deficient rats, raising the possibility of defective conversion of heavier HDL into lighter HDL owing to defective LCAT activity. To test this possibility, rats were injected with emulsion containing radioactive POPC labelled in the oleoyl moiety at the glycerol 2-position. As Fig. 4(a) shows, in control rats little cholesteryl oleate was found 10 min after injection, but increasing amounts were found at later times. By 40 min more labelled cholesteryl oleate was found in the plasma of insulin-deficient rats than in controls, and the difference persisted for 2 h. By 2 h approx. 3 % of the injected radioactivity was present as cholesteryl oleate in the plasma of control rats. As shown in Fig. 4(b) , in insulindeficient rats more labelled cholesteryl oleate was found in the heavier HDL fraction than in the lighter HDL fraction, whereas in controls the ratio was reversed. In insulin-deficient rats the ratio of heavier/lighter HDL decreased progressively with time, whereas in controls the ratio increased slightly with time. Emulsion radioactivities recovered in the liver were similar to those shown in Table 2 , and most label in liver persisted as phospholipid, with < 0.03 % found as cholesteryl oleate in either control or insulin-deficient rats.
Vol. 281 the surfaces of triacylglycerol-rich lipoproteins may have explained the increased exchange with unlabelled heavier HDL phospholipid. As a test for this possibility, emulsion was added to the incubations. When increasing volumes of emulsion were added, more labelled phospholipid was transferred to the d < 1.065 fraction (results not shown). The lipoprotein-free fraction of plasma (d> 1.21) mediated less transfer than did whole plasma.
The rates of transfer of phospholipid label from heavier HDL were measured in incubations of labelled heavier HDL with a fixed volume of emulsion suspended in whole plasma or lipoprotein-free plasma (d > 1.21). More label was transferred to the d < 1.065 fraction in incubations with insulin-deficient plasma than with control plasma, and transfer increased with increasing time of incubation up to 60 min (results not shown).
The effect disappeared when d> 1.21 preparations were used instead of whole plasma, providing additional evidence that the increased transfer in plasma from insulin-deficient rats was due to the increased amounts of triacylglycerol-rich lipoproteins, and not to increased activity of a transfer protein. DISCUSSION We recently demonstrated that labelled phosphatidylcholine was efficiently transferred to plasma HDL from injected emulsions [15] . The introduction of label into HDL by this physiological mechanism facilitated the measurements of the turnover kinetics of HDL phospholipids, with results similar to direct measurements with HDL labelled in phosphatidylcholine [31] or in C18.0-containing sphingomyelin [32] . We have now compared the metabolism of HDL phospholipids in insulindeficient rats with that in normal control rats. On the basis of our previous findings [15, 16] we selected an emulsion stabilized with POPC and labelled with dipalmitoyl phosphatidylcholine, since POPC was a reasonable model for physiological phospholipid species, and the label, being more rapidly removed from plasma than isologous label, would undergo less transfer to cell membranes and to other lipoproteins. Rats were chosen because of the absence of HDL-3 [33] and the absence of cholesteryl ester transfer proteins activity against emulsion cholesteryl oleate [34] .
Clearance of the emulsion phospholipid radioactivity could be divided into an initial rapid phase of about 10 min, in which about 40 % of the label disappeared from plasma, followed by a slower decrease of radioactivity which continued monoexponentially for at least 2 h. The rapid phase of clearance of phospholipid label could be accounted for by the uptake of remnants by the liver [30] . In both control and insulin-deficient rats at least two-thirds of the plasma label was present in HDL 10 min after injection as emulsion, heavier HDL or lighter HDL. Since most of the phospholipid label was found in HDL fractions, the second phase is probably explained by transfer of label to the HDL fraction [13] , followed by the irreversible loss of phospholipid label from the plasma HDL pool by mechanisms that are currently undefined. In the second phase the disappearance of labelled phospholipids from the plasma was slower in insulin-deficient rats than in controls, whether the label was introduced on a triacylglycerol-rich emulsion or as HDL prepared in donor rats ( Fig. 1 (Fig. 3) . However, when emulsion was injected, the pool of d < 1.065 phospholipid in control rats was expanded, abolishing the difference compared with insulindeficient rats (Fig. 2) .
The increased distribution in vivo of label to the d < 1.065 fraction in insulin-deficient rats could have been due to the increased pool of VLDL or to increased phospholipid transfer activity. As shown in Fig. 5 , more label was transferred from heavier HDL in incubations with insulin-deficient plasma compared with controls. Increasing the pool of triacylglycerol by adding increasing volumes of emulsion to incubations in vitro led to increased transfer of phospholipid label from heavier HDL to the d< 1.065 fraction.
The transfer and exchange of phospholipids between lipoproteins is facilitated by a transfer protein from the d> 1.21 fraction of plasma [35, 36] . The increased transfer of phospholipid label to the VLDL + LDL (d < 1.065) fraction of plasma in insulin-deficient rats was not due to an increase in phospholipid transfer activity, because incubations with the d> 1.21 fraction of plasma abolished the consistent differences between control and insulin-deficient rats in the transfer to the d < 1.065 fraction found in incubations with whole plasma.
It has been suggested that LCAT plays a key role in the conversion of heavier HDL into lighter HDL via esterification of free cholesterol [37, 38] . As shown in Fig. 4 , there was no evidence of defective activity of LCAT in insulin-deficient rats, since more cholesteryl oleate was formed in the plasma of insulin-deficient rats than in controls. Studies in vitro of the LCAT rate supported this finding, with slightly higher activity in insulin-deficient rats, although the difference failed to reach statistical significance.
Furthermore, our studies confirmed that the metabolism of phospholipids by LCAT was slow in comparison with the exchange of phospholipid radioactivity between the fractions.
Only about 1-2 % of the phospholipid label was consumed by this pathway in either control [15] or insulin-deficient rats.
Plasma phospholipids exchange rapidly between HDL and other lipoproteins. The equilibrium distribution of label presumably reflects the size of each fraction of the phospholipid pool. In insulin-deficient rats the changes in HDL phospholipid clearance and exchange appear to be secondary to the associated hypertriglyceridaemia, consistent with measurements in vitro, where the transfer of phospholipid from HDL to emulsion was proportional to the quantity of added emulsion [34] .
